Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
Cardiovascular Diseases | 0.830 | 1.000 | 5 | 2011 | 2019 | |||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
0.800 | 1.000 | 4 | 2009 | 2019 | ||||||||
|
0.851 | 0.240 | 11 | 61828092 | intron variant | C/T | snv | 0.11 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.810 | 1.000 | 4 | 2009 | 2019 | |||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
0.800 | 1.000 | 3 | 2009 | 2019 | ||||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
0.700 | 1.000 | 3 | 2016 | 2019 | ||||||||
|
1.000 | 0.080 | 11 | 61811991 | intron variant | A/G | snv | 0.40 | 0.28 |
|
0.700 | 1.000 | 3 | 2015 | 2019 | |||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
0.800 | 1.000 | 2 | 2011 | 2016 | ||||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
0.800 | 1.000 | 2 | 2012 | 2016 | ||||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
0.700 | 1.000 | 2 | 2010 | 2013 | ||||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
0.800 | 1.000 | 2 | 2011 | 2016 | ||||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2015 | 2019 | |||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
Nutritional and Metabolic Diseases | 0.020 | 1.000 | 2 | 2019 | 2019 | |||||||
|
1.000 | 0.080 | 11 | 61811991 | intron variant | A/G | snv | 0.40 | 0.28 |
|
0.700 | 1.000 | 2 | 2018 | 2019 | |||||||
|
1.000 | 0.080 | 11 | 61811991 | intron variant | A/G | snv | 0.40 | 0.28 |
|
0.700 | 1.000 | 2 | 2018 | 2019 | |||||||
|
1.000 | 0.080 | 11 | 61811991 | intron variant | A/G | snv | 0.40 | 0.28 |
|
0.700 | 1.000 | 2 | 2018 | 2019 | |||||||
|
11 | 61812288 | intron variant | T/C | snv | 0.26 |
|
0.700 | 1.000 | 2 | 2012 | 2013 | ||||||||||
|
0.925 | 0.160 | 11 | 61813163 | intron variant | C/T | snv | 0.26 |
|
0.700 | 1.000 | 2 | 2012 | 2013 | ||||||||
|
0.925 | 0.040 | 11 | 61824435 | intron variant | G/A | snv | 0.14 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.040 | 11 | 61824435 | intron variant | G/A | snv | 0.14 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
0.700 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
Endocrine System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
0.700 | 1.000 | 1 | 2016 | 2016 |